Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
161 studies found for:    Open Studies | "Mycoses"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
Condition: Mycosis Fungoides
Interventions: Biological: A-dmDT390-bisFv(UCHT1);   Drug: Vorinostat
2 Not yet recruiting Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method
Condition: Mycoses
Intervention:
3 Recruiting Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Intervention: Drug: Valchlor
4 Recruiting Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: Campath-1H
5 Recruiting TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Conditions: Mycosis Fungoides;   Sézary Syndrome
Interventions: Radiation: TSEB Therapy;   Drug: Brentuximab vedotin
6 Not yet recruiting Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides
Conditions: Mycosis Fungoides;   Cutaneous T-cell Lymphoma
Interventions: Radiation: Total skin electron beam therapy (TSEBT);   Drug: mechlorethamine gel 0.016%
7 Recruiting Fungiscope - A Global Emerging Fungal Infection Registry
Condition: Invasive Fungal Disease
Intervention:
8 Not yet recruiting ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Conditions: Mycosis Fungoides;   Non-Hodgkin's Lymphoma
Intervention:
9 Recruiting Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides
Conditions: Recurrent Mycosis Fungoides;   Refractory Mycosis Fungoides;   Stage I Mycosis Fungoides;   Stage II Mycosis Fungoides;   Stage III Mycosis Fungoides
Interventions: Other: Quality-of-Life Assessment;   Other: Objective Grading of Skin Findings
10 Recruiting Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
Condition: Invasive Fungal Infections
Intervention: Other: Peripheral blood sampling
11 Recruiting Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
Conditions: Mycosis Fungoides;   Sezary Syndrome;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: resminostat;   Drug: Placebo
12 Not yet recruiting Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome
Condition: Mycoses
Intervention:
13 Recruiting Effect of Inflammation on Pharmacokinetics of Posaconazole
Condition: Mycoses
Intervention: Drug: posaconazole
14 Recruiting Safety, Tolerability and Pharmacokinetic Study of MRG-106 in Patients With Cutaneous T Cell Lymphoma (CTCL), MF Subtype
Conditions: Cutaneous T-cell Lymphoma (CTCL);   Mycosis Fungoides
Intervention: Drug: MRG-106
15 Not yet recruiting Naloxone Hydrochloride Study for Relief of Pruritus in Patients With Mycosis Fungoides (MF) Form of CTCL
Conditions: Mycosis Fungoides;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: Naloxone Hydrochloride Lotion, 0.5%;   Drug: Placebo Lotion
16 Recruiting Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Conditions: Fungal Infection;   Hematopoietic/Lymphoid Cancer
Interventions: Drug: caspofungin acetate;   Drug: fluconazole;   Drug: voriconazole;   Other: laboratory biomarker analysis
17 Not yet recruiting Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Interventions: Drug: 3.75% Imiquimod Cream;   Drug: 0.1% Fluocinonide Cream
18 Recruiting MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
Condition: Fungal Infection
Intervention: Drug: Voriconazole
19 Recruiting Early Diagnosis of Mycosis Fungoides
Condition: Cutaneous T Cell Lymphoma
Intervention: Other: Blood sampling
20 Recruiting Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
Condition: Fungal Infection
Interventions: Drug: APX001 single IV dose;   Drug: APX001 single oral dose 1;   Drug: APX001 single oral dose 2;   Drug: APX001 single oral dose 3;   Drug: APX001 single oral dose fasted;   Drug: APX001 single oral dose fed;   Drug: APX001 multiple oral doses 1;   Drug: APX001 multiple oral doses 2;   Drug: APX001 multiple oral doses 3;   Drug: Cytochrome P450 substrates;   Drug: Matching placebo control

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.